UBS Global Wealth Management wins mandate

UBS Global Wealth Management (UBS GWM) has been awarded an investment adviser mandate by the Peter MacCallum Cancer Foundation for the third time running.

Peter MacCallum Cancer Foundation chief executive Craig Connelly said the long-standing partnership with UBS has built on more than a decade of trust and shared commitment to impact.

"Their proven investment expertise will help us maximise the value of philanthropic funds, strengthening our ability to invest in the future of personalised cancer care and accelerate the breakthroughs that matter most to patients," Connelly said.

Based in Melbourne, the Peter MacCallum Cancer Foundation conducts advanced cancer research at the Peter MacCallum Cancer Centre.

As the fundraising arm of the hospital, its primary purpose is to accelerate the pace of discovery and innovation in the field of oncology.

Funds raised by the foundation are directed towards supporting researchers and scientists at the hospital.

The Peter MacCallum Cancer Centre cares for some 50,000 patients each year and employs 750 researchers.

UBS GWM Australia head of not-for-profit advisory Zarmeen Pavri said: "Our third-term reappointment with the Peter MacCallum Cancer Foundation builds on over a decade of trusted partnership and reflects our commitment beyond traditional investment advisory."

The partnership aims to ensure strong financial stewardship that underpins the breakthroughs that improve and save lives, advancing world-class cancer research and supporting the broader medical research sector to deliver lasting impact, Pavri said.

For charitable endowments and foundations, UBS GWM offers advice and investment solutions for clients, across strategic asset allocation, discretionary portfolio management, portfolio risk management, investment governance, custody and reporting.